Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-07-01 | Dennis H. Langer: Director of pharmaceutical and biotech companies; Chairman and CEO of AdvanDx; qualifications include Finance, Leadership, Research and Development. |
| 2022-04-26 | Dr. Langer received a J.D. from Harvard Law School, an M.D. from Georgetown University School of Medicine, and a B.A. in Biology from Columbia University. Dr. Langer’s qualifications to serve on our Board of Directors include his experience in company strategy, operations, corporate development and financing as a former pharmaceutical executive and CEO of bio-pharmaceutical companies. |
Data sourced from SEC filings. Last updated: 2025-07-01